Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
Also known as: Chronic Rhinosinusitis With Nasal Polyps / Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Chronic Rhinosinusitis With Nasal Polyposis / Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) / Chronic rhinosinusitis with multiple nasal polyps (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB12159 | Dupilumab | A monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults. |
DB06612 | Mepolizumab | A fully-humanized monoclonal IgG1 kappa anti-IL-5 antibody used in conjunction with other therapies to treat severe asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. |
DB14512 | Mometasone furoate | A corticosteroid used to treat asthma, allergic rhinitis, nasal congestion, nasal polyps, dermatitis, and pruritus. |
DB00043 | Omalizumab | A monoclonal anti-immunoglobulin E (IgE) antibody used to treat asthma, chronic idiopathic urticaria, chronic rhinosinusitis with nasal polyps, and IgE-mediated food allergy. |